InsiderGauge
Checking updates…
Dashboard

Tsuchimoto Kim Rinsider trades

In SEC Form 4 filings, Tsuchimoto Kim R is listed as Director of Monopar Therapeutics (MNPR). In the last 90 days, Tsuchimoto Kim R sold $455.6K of Monopar Therapeutics (MNPR) on the open market and bought none. All 6 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
MNPRMonopar TherapeuticsDirector10Aug 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-28

Dashed line = amended filing (Form 4/A)

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
MNPRMonopar TherapeuticsAug 26Aug 284/AM2,055$30.00$61,6502,055YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AM2,035$14.00$28,4904,090YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AS485$108.83Sale −$52,7833,605YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AS615$109.56Sale −$67,3792,990YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AS700$110.65Sale −$77,4552,290YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AS1,098$111.84Sale −$122,8001,192YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AS602$112.93Sale −$67,984590YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AS590$113.84Sale −$67,166not reportedYesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AM · derivative2,055$30.00$61,6506,165YesForm 4/A
MNPRMonopar TherapeuticsAug 26Aug 284/AM · derivative2,035$14.00$28,4908,140YesForm 4/A

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.